COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants
Jesse O. Wrenn(Vanderbilt University Medical Center), Suman Pakala(Vanderbilt University Medical Center), Grant Vestal(Vanderbilt University Medical Center), Meghan H. Shilts(Vanderbilt University Medical Center), Hunter M. Brown(Vanderbilt University Medical Center), Sara M. Bowen(Vanderbilt University Medical Center), Britton A. Strickland(Vanderbilt University Medical Center), Timothy J. Williams(Vanderbilt University Medical Center), S. Mallal(Vanderbilt University Medical Center), Ian D. Jones(Vanderbilt University Medical Center), Jonathan E. Schmitz(Vanderbilt University Medical Center), Wesley H. Self(Vanderbilt University Medical Center), Suman R. Das(Vanderbilt University Medical Center)
Cited by 103Open Access
Abstract
The Omicron variant of SARS-CoV-2 achieved worldwide dominance in late 2021. Early work suggests that infections caused by the Omicron variant may be less severe than those caused by the Delta variant. We sought to compare clinical outcomes of infections caused by these two strains, confirmed by whole genome sequencing, over a short period of time, from respiratory samples collected from SARS-CoV-2 positive patients at a large medical center. We found that infections caused by the Omicron variant caused significantly less morbidity, including admission to the hospital and requirement for oxygen supplementation, and significantly less mortality than those caused by the Delta variant.
Related Papers
No related papers found
Powered by citation graph analysis